News for 'diagnostics'

AIIMS-Like Centre For Animals In Delhi

AIIMS-Like Centre For Animals In Delhi

Rediff.com25 Sep 2023

The Centre, for the first time, has initiated a draft proposal for setting up an All India Institute of Medical Sciences (AIIMS)-like institute of national importance for animal health, education and research in Delhi to be called the All India Institute of Veterinary Sciences (AIIVS).

India, US to end 6 WTO disputes, Delhi to drop tit-for-tat tariffs

India, US to end 6 WTO disputes, Delhi to drop tit-for-tat tariffs

Rediff.com23 Jun 2023

In a major development, India and the US have agreed to end six trade disputes at the WTO through mutually agreed solutions, while New Delhi will remove retaliatory customs duties on certain American products such as almonds, walnuts, and apples.

ICMR doing 3 studies on post-Covid heart attack among young

ICMR doing 3 studies on post-Covid heart attack among young

Rediff.com21 Jul 2023

The Indian Council of Medical Research is conducting three different studies to ascertain the facts regarding rising cases of cardiac arrest after the pandemic, Mandaviya said in response to a question in the Lok Sabha.

ISRO likely to launch Sun mission Aditya L1 on Sept 2

ISRO likely to launch Sun mission Aditya L1 on Sept 2

Rediff.com26 Aug 2023

Aditya-L1 spacecraft is designed for providing remote observations of the solar corona and in situ observations of the solar wind at L1 (Sun-Earth Lagrangian point), which is about 1.5 million kilometres from the earth.

India business to put a spring in pharma's step

India business to put a spring in pharma's step

Rediff.com26 Apr 2023

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.

DNA samples of hair, bones recovered match Shraddha's father

DNA samples of hair, bones recovered match Shraddha's father

Rediff.com4 Jan 2023

The bones and hair were recovered during searches from forest areas of Delhi NCR including Gurgaon and Mehrauli, the police said.

Breast Self-Exam: How to Perform, What to Look For

Breast Self-Exam: How to Perform, What to Look For

Rediff.com3 Nov 2022

Dr Vijay Haribhakti, oncologist, Sir HN Reliance Hospital, Mumbai, offers expert guidance on how to perform a self breast examination at home.

At 21.4 lakh, India sees 18% spike in TB cases in 2021

At 21.4 lakh, India sees 18% spike in TB cases in 2021

Rediff.com28 Oct 2022

Under the Pradhan Mantri TB Mukt Bharat Abhiyan, an initiative of the government, more than 40,000 Nikshay Mitra are supporting over 10.45 lakh TB patients all over the country presently, the Union health ministry said.

Delhi court orders manhandling CCTV footage be given to Sisodia

Delhi court orders manhandling CCTV footage be given to Sisodia

Rediff.com19 Jul 2023

The judge noted that following an earlier court order, the official concerned of Rouse Avenue District Courts premises had brought the CCTV footage of May 23 pertaining to production of Sisodia before the court in the case.

Influenza A subtype behind rise in cough, fever cases across country

Influenza A subtype behind rise in cough, fever cases across country

Rediff.com4 Mar 2023

The H3N2, which has been in wide circulation for the past two-three months, causes more hospitalisations than other subtypes, said ICMR scientists who keep a close watch on ailments caused by respiratory viruses through the Virus Research and Diagnostic Laboratories network.

IPO frenzy continues; 2 public issues to open on Sep 1

IPO frenzy continues; 2 public issues to open on Sep 1

Rediff.com29 Aug 2021

The IPO rush will continue in September with two more companies Vijaya Diagnostic Centre and Ami Organics launching their initial share-sales on Wednesday to raise a total of Rs 2,465 crore. This comes after eight companies including Devyani International, Nuvoco Vistas Corporation and CarTrade Tech floated their initial share-sales last month to mobilise Rs 18,243 crore. So far in the current fiscal, a total of 20 companies have mopped up more than Rs 45,000 crore through IPOs. This is much higher than Rs 31,277 crore raised by 30 firms in the entire 2020-21.

After cement, Adani to foray into healthcare

After cement, Adani to foray into healthcare

Rediff.com19 May 2022

Billionaire Gautam Adani's group has created a new company for its foray into healthcare services through the acquisition of large hospitals, diagnostic chains, and offline and digital pharmacies. Adani Enterprises Ltd - the group's business incubator firm - in a regulatory filing said a wholly-owned subsidiary, Adani Health Ventures Ltd (AHVL) was incorporated on May 17, 2022. AVHL will "carry on the business of healthcare-related activities including, inter alia, setting up, running, administrating medical and diagnostic facilities, health aids, health tech-based facilities, research centers and to do all other allied and incidental activities in this regard," it said.

'Some' foreign flyers test Covid positive at Delhi airport

'Some' foreign flyers test Covid positive at Delhi airport

Rediff.com26 Dec 2022

At the Delhi airport, as many as 455 passengers have been subjected to random coronavirus testing, starting from 10 am on Saturday till 7 pm on Sunday. Out of them, less than half per cent are positive cases, an official at Genestrings Diagnostic Centre said.

Regulatory woes torpedo PE/VC deals in e-pharma sector

Regulatory woes torpedo PE/VC deals in e-pharma sector

Rediff.com27 Jun 2023

With regulatory uncertainties clouding the future of online pharmacies, deals in the space are showing signs of slowdown, as also fresh investment from private-equity (PE) firms and venture capitalists (VCs). The data from Venture Intelligence shows so far in 2023 (as of June 13) there has been one deal with PE-VC funding. In 2022 there were four, a sharp fall from the 12, totalling $1,520 million, the sector had attracted in 2021.

Gujarat firm gets licence to make covid-19 test kits

Gujarat firm gets licence to make covid-19 test kits

Rediff.com22 Mar 2020

A joint venture of Synbiotics, a wholly owned subsidiary of Ambalal Sarabhai Enterprises (ASE), and CoDiagnostics, CoSara Diagnostics is the first and only Indian company so far to receive a licence from the Central Drugs Standard Control Organisation (CDSCO) to manufacture coronavirus diagnostic test kits.

Import of key Chinese medical devices rises up to 152% till Dec FY23

Import of key Chinese medical devices rises up to 152% till Dec FY23

Rediff.com5 May 2023

In the first nine months of financial year 2022-23, India's exports of medical devices have grown by 17 per cent, while imports have declined by around 8 per cent, show the latest data compiled by the Association of Indian Medical Device Industry (AiMeD). However, import of 30 medical devices from China has risen between 25 per cent and 152 per cent during this period, the AiMeD has written to Commerce and Industries Minister Piyush Goyal in March. The AiMeD is an umbrella organisation of medical device makers.

Chhattisgarh's 'Hamar Lab' is a medical game-changer

Chhattisgarh's 'Hamar Lab' is a medical game-changer

Rediff.com19 Jul 2022

Globally recognised organisations including the CDC, the Clinton Foundation, and domestic pharmaceutical and health care companies have sent their teams to visit the centres and study the concept, reports R Krishna Das.

Meghalaya govt unveils Asia's first drone delivery hub

Meghalaya govt unveils Asia's first drone delivery hub

Rediff.com6 Dec 2022

The Meghalaya government in partnership with startup TechEagle has unveiled Asia's first drone delivery hub and network which is aimed at providing universal access to healthcare for the people in the state, a release said on Tuesday. The project is aimed at delivering vital supplies like drugs, diagnostic samples, vaccines, blood and blood components quickly and safely to different regions of the state using a dedicated drone delivery network, it said. On Monday, the first official drone flight took off from Jengjal Sub Divisional Hospital, which will act as the hub, and delivered medicines to Padeldoba primary health centre in less than 30 minutes, which would otherwise have taken 2.5 hours by road, TechEagle said in the release.

COVID-19 Cases: No Reason For Alarm

COVID-19 Cases: No Reason For Alarm

Rediff.com16 Mar 2023

'The fortunate part is that the severity is less. New strains are continuously forming and the virus is getting less severe.'

Automobile retail sales up 14% in March; post 21% YoY growth in FY23

Automobile retail sales up 14% in March; post 21% YoY growth in FY23

Rediff.com12 Apr 2023

Automotive retail sales saw a 14 per cent rise in March on a year-on-year (YoY) basis, according to data released by the Federation of Automobile Dealers Associations (FADA). For the whole of financial year 2022-23 (FY23), sales grew 21 per cent YoY. For both March and the financial year, all categories, except for tractors, and including two-wheelers, three-wheelers, passenger vehicles (PVs), and commercial vehicles (CVs), posted double-digit growth. However, the total retail sales of 22.1 million for the financial year were still 12 per cent lower than the pre-Covid (FY20) level of 25 million, owing to an 18 per cent dip in the two-wheeler segment.

Suman Chakraborty Is Revolutionising Rural Healthcare

Suman Chakraborty Is Revolutionising Rural Healthcare

Rediff.com24 Jan 2023

'If you can simplify the technology, you don't need a doctor or a highly qualified technician to work on the technology; even an Asha health worker or a similar front line health worker can use it with minimal training.'

Does This Budget Do Enough For Health?

Does This Budget Do Enough For Health?

Rediff.com9 Feb 2023

'For free supply of drugs and medicines itself, almost Rs 20,000 crores would be required.'

Cancer Research Is Hampered By Lack Of Racial Data

Cancer Research Is Hampered By Lack Of Racial Data

Rediff.com2 May 2023

Cancer has no race, so why do new innovative cancer drugs discriminate based on race and ethnic groups, asks Digonto Chatterjee.

Two key factors that will drive gains for Bosch stock

Two key factors that will drive gains for Bosch stock

Rediff.com8 Apr 2023

The stock of auto component major Bosch was up 2.5 per cent on Wednesday and in the process hit its 52-week high. Expectations of higher volumes of medium and heavy commercial vehicles' (M&HCV), rise in content supplies on account of BS VI stage 2 implementation from April, and improved profitability are some of the positives for the stock. In addition to this, the company appointed a new managing director and joint managing director last week, which will come into effect from July 1.

3 Pilots Tested Positive For Psychotropic Substances

3 Pilots Tested Positive For Psychotropic Substances

Rediff.com27 Aug 2022

commercial airlines and air navigation service providers have to carry out random drug tests on at least 10 per cent of their flight crew and air traffic controllers every year.

How India Can Rival China As Production Platform

How India Can Rival China As Production Platform

Rediff.com28 Jul 2023

We have the workforce, now we need to ensure that we take full advantage of game-changing technologies and geopolitical openings, suggests Jayant Sinha, chairman, Parliament's Standing Committee on Finance.

Scientists design infertility diagnostic kit

Scientists design infertility diagnostic kit

Rediff.com7 Jan 2005

Their research may be significant for cancer treatment too.

Centre's Omicron FAQ says mutations may lessen vaccine efficacy

Centre's Omicron FAQ says mutations may lessen vaccine efficacy

Rediff.com3 Dec 2021

The Union health ministry on Friday said while there is no evidence to suggest that existing vaccines do not work on the Omicron variant of SARS-CoV-2, some of the mutations reported may decrease the efficacy of the jabs.

10 Tips To Have A Baby After 35

10 Tips To Have A Baby After 35

Rediff.com14 Jul 2023

If you are considering pregnancy, it is advisable to meet with a healthcare provider to discuss your overall health, any pre-existing conditions, and any steps you can take to optimise your health before conceiving, advises Dr Kiran Coelho.

India forms monkeypox taskforce after patient's death

India forms monkeypox taskforce after patient's death

Rediff.com1 Aug 2022

A 22-year-old man, who recently returned to Kerala from the UAE, allegedly died due to monkeypox on Saturday.

Uniform Civil Code, NRC, freebies in BJP's K'taka poll manifesto

Uniform Civil Code, NRC, freebies in BJP's K'taka poll manifesto

Rediff.com1 May 2023

It also promised to launch the 'Poshane' scheme through which every BPL household will be provided with half litre 'Nandini' milk every day and five kg 'Shri Anna - siri dhanya' through monthly ration kits.

COVID-19 second wave: Delays in RT-PCR tests

COVID-19 second wave: Delays in RT-PCR tests

Rediff.com9 May 2021

While there is a shortage of testing kits, manpower and capacities, India does not have other scalable testing options.

China making virus deadlier than Covid in Pakistan: Report

China making virus deadlier than Covid in Pakistan: Report

Rediff.com6 Nov 2022

According to various global media reports, China is creating Covid-like pathogens in Pakistan that have the potential of causing virus contamination on a scale far higher than Covid.

August 4 was the busiest day for IPOs since 2007

August 4 was the busiest day for IPOs since 2007

Rediff.com5 Aug 2021

Retail investors-those investing up to Rs 200,000-lapped up all the four initial public offerings (IPOs) that opened for subscription on Wednesday. This is the first time since 2007 that four IPOs have been launched on a single day, according to information provided by Prime Database. KFC and Pizza Hut franchisee Devyani International (size Rs 1,838 crore); Diagnostic chains Krsnaa Diagnostics (Rs 1,213 crore), pharmaceutical firm Windlas Biotech (Rs 401 crore) and vitrified tiles manufacturer Exxaro Tiles (Rs 161 crore) are the four companies whose IPOs opened on Wednesday.

Centre concerned over Covid positivity rate spike amid H3N2 cases

Centre concerned over Covid positivity rate spike amid H3N2 cases

Rediff.com11 Mar 2023

The states were requested to take a stock of hospital preparedness such as availability of drugs and medical oxygen, vaccination coverage against COVID-19 and influenza.

Tata Motors may hike prices of passenger vehicles from Jan

Tata Motors may hike prices of passenger vehicles from Jan

Rediff.com5 Dec 2022

Tata Motors is looking to increase passenger vehicle prices from next month in order to make its model range compliant with stricter emission norms which kick in from April 1 next year, according to a top company official. In an interaction with PTI, Tata Motors Managing Director - Passenger Vehicle and Electric Vehicles Shailesh Chandra said the price revision would also offset the impact of commodity prices, which have remained high for the most part of the year. "The regulatory change will have its impact on the cost. Even the real impact of softening of commodity prices is only going to come from next quarter and we still have the residual impact of the commodity escalation that we have seen during the year," Chandra said.

A Lifetime In Pursuit Of Precision In Psychiatry

A Lifetime In Pursuit Of Precision In Psychiatry

Rediff.com3 Mar 2023

Dr Rajesh M Parikh remembers Dr Dinshaw Doongaji, the legendary psychiatrist who passed into the ages last week, a day short of his 91st birthday.

Street cheers auto volume data amid interest rate, chip crunch concerns

Street cheers auto volume data amid interest rate, chip crunch concerns

Rediff.com11 Apr 2023

The automobile sector is considered a good indicator of economic health. It has a very long value chain, from primary materials, like metals, glass and plastic, to value-added high-end electronic components, specialised alloys, and software.

Tata Tiago.ev: The Electric Temptress

Tata Tiago.ev: The Electric Temptress

Rediff.com22 Dec 2022

It is a perfect city car for both your daily office commute and fun weekend drives.

Demand for Covid-19 tests growing 100 pc week-on-week

Demand for Covid-19 tests growing 100 pc week-on-week

Rediff.com23 Apr 2021

One challenge for many laboratories in ramping up is the shortage of trained manpower for collecting samples, report Sohini Das, Vinay Umarji and Virendra Singh Rawat.